RING1 | ring finger protein 1 | 0.958 | |
RNF2 | ring finger protein 2 | 0.910 | |
CBX8 | chromobox homolog 8 | 0.875 | |
BMI1 | BMI1 polycomb ring finger oncogene | 0.828 | |
CDC27 | cell division cycle 27 homolog (S. cerevisiae) | 0.729 | |
UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.673 | |
CBX7 | chromobox homolog 7 | 0.589 | |
SIRT2 | sirtuin 2 | 0.448 | |
USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.390 | |
ARIH2 | ariadne homolog 2 (Drosophila) | 0.341 | |
CTAG1B | cancer/testis antigen 1B | 0.259 | |
NAP1L5 | nucleosome assembly protein 1-like 5 | 0.205 | |
TEKT4 | tektin 4 | 0.180 | |
MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | 0.178 | |
CBX6 | chromobox homolog 6 | 0.163 | |
RNF144B | ring finger protein 144B | 0.159 | |
PJA1 | praja ring finger 1 | 0.140 | |
EID2 | EP300 interacting inhibitor of differentiation 2 | 0.139 | |
PLK1 | polo-like kinase 1 | 0.124 | |
FHL1 | four and a half LIM domains 1 | 0.123 | |
UBE3A | ubiquitin protein ligase E3A | 0.119 | |
FZR1 | fizzy/cell division cycle 20 related 1 (Drosophila) | 0.101 | |
CBX4 | chromobox homolog 4 | 0.097 | |
USP11 | ubiquitin specific peptidase 11 | 0.091 | |
GSK3B | glycogen synthase kinase 3 beta | 0.083 | |
NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.082 | |
EID2B | EP300 interacting inhibitor of differentiation 2B | 0.079 | |
MAGEA1 | melanoma antigen family A, 1 (directs expression of antigen MZ2-E) | 0.071 | |
ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.061 | |
RYBP | RING1 and YY1 binding protein | 0.061 | |
RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.060 | |
AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | 0.060 | |
IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.059 | |
SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.058 | |
MAGEA12 | melanoma antigen family A, 12 | 0.058 | |
MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.056 | |
ATF5 | activating transcription factor 5 | 0.048 | |
ADRB2 | adrenergic, beta-2-, receptor, surface | 0.048 | |
RNF11 | ring finger protein 11 | 0.046 | |
MAGEA3 | melanoma antigen family A, 3 | 0.045 | |
LNX1 | ligand of numb-protein X 1 | 0.044 | |
MAGEA6 | melanoma antigen family A, 6 | 0.044 | |
BCOR | BCL6 corepressor | 0.043 | |
GCLC | glutamate-cysteine ligase, catalytic subunit | 0.042 | |
BIRC3 | baculoviral IAP repeat containing 3 | 0.039 | |
MYST1 | MYST histone acetyltransferase 1 | 0.037 | |
PRNP | prion protein | 0.037 | |
APLF | aprataxin and PNKP like factor | 0.037 | |
CCDC6 | coiled-coil domain containing 6 | 0.036 | |
MAGEA5 | melanoma antigen family A, 5 | 0.036 | |
BAX | BCL2-associated X protein | 0.035 | |
EID3 | EP300 interacting inhibitor of differentiation 3 | 0.035 | |
UBE2M | ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast) | 0.033 | |
LIG4 | ligase IV, DNA, ATP-dependent | 0.031 | |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.031 | |
PCGF1 | polycomb group ring finger 1 | 0.030 | |
CLSPN | claspin | 0.030 | |
DAXX | death-domain associated protein | 0.030 | |
TRIM69 | tripartite motif containing 69 | 0.029 | |
KAT5 | K(lysine) acetyltransferase 5 | 0.029 | |
UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.028 | |
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.026 | |
PCGF5 | polycomb group ring finger 5 | 0.025 | |
NRIP1 | nuclear receptor interacting protein 1 | 0.025 | |
TUBB2C | tubulin, beta 2C | 0.025 | |
SUFU | suppressor of fused homolog (Drosophila) | 0.024 | |
PML | promyelocytic leukemia | 0.022 | |
PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.022 | |
TNIP1 | TNFAIP3 interacting protein 1 | 0.022 | |
TRIM28 | tripartite motif containing 28 | 0.022 | |
MOAP1 | modulator of apoptosis 1 | 0.020 | |
MAGEA2 | melanoma antigen family A, 2 | 0.020 | |
MAK | male germ cell-associated kinase | 0.020 | |
MAGEC1 | melanoma antigen family C, 1 | 0.020 | |
EID1 | EP300 interacting inhibitor of differentiation 1 | 0.019 | |
PCGF3 | polycomb group ring finger 3 | 0.019 | |
PCGF2 | polycomb group ring finger 2 | 0.018 | |
EIF2S2 | eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa | 0.018 | |
POLR2C | polymerase (RNA) II (DNA directed) polypeptide C, 33kDa | 0.017 | |
PSMA3 | proteasome (prosome, macropain) subunit, alpha type, 3 | 0.017 | |
WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.017 | |
UBE2L3 | ubiquitin-conjugating enzyme E2L 3 | 0.016 | |
YAF2 | YY1 associated factor 2 | 0.016 | |
DDIT4 | DNA-damage-inducible transcript 4 | 0.016 | |
GET4 | golgi to ER traffic protein 4 homolog (S. cerevisiae) | 0.015 | |
BIRC2 | baculoviral IAP repeat containing 2 | 0.015 | |
ERH | enhancer of rudimentary homolog (Drosophila) | 0.015 | |
RBX1 | ring-box 1, E3 ubiquitin protein ligase | 0.015 | |
SYVN1 | synovial apoptosis inhibitor 1, synoviolin | 0.015 | |
CSNK2B | casein kinase 2, beta polypeptide | 0.015 | |
RANGAP1 | Ran GTPase activating protein 1 | 0.014 | |
EIF4E | eukaryotic translation initiation factor 4E | 0.014 | |
PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.014 | |
NHEJ1 | nonhomologous end-joining factor 1 | 0.014 | |
HSPA1L | heat shock 70kDa protein 1-like | 0.014 | |
TUBG1 | tubulin, gamma 1 | 0.014 | |
MAGEA4 | melanoma antigen family A, 4 | 0.013 | |
DEAF1 | deformed epidermal autoregulatory factor 1 (Drosophila) | 0.013 | |
PTTG1 | pituitary tumor-transforming 1 | 0.013 | |
MAGEB2 | melanoma antigen family B, 2 | 0.012 | |